Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

MAP2K1 Mouse anti-Canine, Human, Mouse, Clone: OTI3E6, liquid, TrueMAB™ Non-distribution product as customer accommodation.

Mouse Monoclonal Antibody

Manufacturer:  OriGeneSupplier Diversity Partner TA506108

Catalog No. 50-167-6459


Add to cart

Description

Description

MEK1 (mitogen activated protein kinase kinase, ERK kinase 1, microtubule-associated protein 2 kinase) is a dual specificity kinase and catalyses both a threonine and a tyrosine residue on MAP kinases ERK1 and ERK2. Mek1 is activated by phosphorylation of serine 218 and 222 residues by Raf1. It is known to be involved in the signaling during stress activate response, apoptosis and proliferative induction by cytokines. Mutations in MEK1 can lead to cardiofaciocutaneous syndrome.
Specifications

Specifications

MAP2K1
Monoclonal
1 mg/mL
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide
P31938, Q02750
CFC3, MAPKK1, MEK1, MKK1, PRKMK1
Mouse
IgG1
100 μL
-20° C, Avoid Freeze/Thaw Cycles
Primary
26395, 478347, 5604
Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
OTI3E6
Unconjugated
MAP2K1
Liquid
MAP2K1
Full length human recombit protein of human MAP2K1 produced in HEK293T cell.
Affinity Chromatography
RUO
Antibody
Monoclonal
Canine, Human, Mouse
Documents
Provide Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit